U.S. markets closed
  • S&P 500

    3,465.39
    +11.90 (+0.34%)
     
  • Dow 30

    28,335.57
    -28.09 (-0.10%)
     
  • Nasdaq

    11,548.28
    +42.28 (+0.37%)
     
  • Russell 2000

    1,640.50
    +10.25 (+0.63%)
     
  • Crude Oil

    39.78
    -0.86 (-2.12%)
     
  • Gold

    1,903.40
    -1.20 (-0.06%)
     
  • Silver

    24.70
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1868
    +0.0042 (+0.36%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • GBP/USD

    1.3038
    -0.0042 (-0.32%)
     
  • USD/JPY

    104.6900
    -0.1500 (-0.14%)
     
  • BTC-USD

    12,951.17
    +46.18 (+0.36%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,516.59
    +42.32 (+0.18%)
     

Eczema Therapeutics Market- Roadmap for Recovery from COVID-19 | Geopolitical Uncertainties to Boost the Market Growth | Technavio

·6 mins read

Technavio has been monitoring the eczema therapeutics market and it is poised to grow by USD 3.60 bn during 2020-2024, progressing at a CAGR of over 9% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200925005337/en/

Technavio has announced its latest market research report titled Global Eczema Therapeutics Market 2020-2024 (Graphic: Business Wire)

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts

Frequently Asked Questions:

  • What are the major trends in the market?
    Increasing healthcare expenditure is a major trend driving the growth of the market.

  • At what rate is the market projected to grow?
    The year-over-year growth for 2020 is estimated at 7.09% and the incremental growth of the market is anticipated to be $ 3.60 bn.

  • Who are the top players in the market?
    AbbVie Inc., Alliance Pharma Plc., Bausch Health Companies Inc., Bayer AG, Eli Lilly and Co., Encore Dermatology Inc., LEO Pharma AS, Mylan NV, Pfizer Inc., and Sanofi are some of the major market participants.

  • What are the key market drivers?
    The geopolitical uncertainties is one of the major factors driving the market.

  • How big is the North America market?
    The North America region will contribute 41% of the market share.

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. AbbVie Inc., Alliance Pharma Plc., Bausch Health Companies Inc., Bayer AG, Eli Lilly and Co., Encore Dermatology Inc., LEO Pharma AS, Mylan NV, Pfizer Inc., and Sanofi are some of the major market participants. The geopolitical uncertainties will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

Eczema Therapeutics Market 2020-2024: Segmentation

Eczema Therapeutics Market is segmented as below:

  • Indication

    • Atopic Dermatitis

    • Contact Dermatitis

    • Other Indication

  • Geographic Landscape

    • Asia

    • Europe

    • North America

    • ROW

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40707

Eczema Therapeutics Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The eczema therapeutics market report covers the following areas:

  • Eczema Therapeutics Market Size

  • Eczema Therapeutics Market Trends

  • Eczema Therapeutics Market Industry Analysis

This study identifies increasing healthcare expenditure as one of the prime reasons driving the eczema therapeutics market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform

Eczema Therapeutics Market 2020-2024: Key Highlights

  • CAGR of the market during the forecast period 2020-2024

  • Detailed information on factors that will assist eczema therapeutics market growth during the next five years

  • Estimation of the eczema therapeutics market size and its contribution to the parent market

  • Predictions on upcoming trends and changes in consumer behavior

  • The growth of the eczema therapeutics market

  • Analysis of the market’s competitive landscape and detailed information on vendors

  • Comprehensive details of factors that will challenge the growth of eczema therapeutics market vendors

Table of Contents:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • Preface

  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem

  • Market characteristics

  • Market segmentation analysis

  • Value chain analysis

PART 04: MARKET SIZING

  • Market definition

  • Market sizing 2019

  • Market size and forecast 2019-2024

  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

PART 06: CUSTOMER LANDSCAPE

PART 07: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • Asia - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity

PART 08: MARKET SEGMENTATION BY INDICATION

  • Market segmentation by indication

  • Comparison by indication

  • Atopic dermatitis - Market size and forecast 2019-2024

  • Contact dermatitis - Market size and forecast 2019-2024

  • Other indication - Market size and forecast 2019-2024

  • Market opportunity by indication

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers

  • Market challenges

PART 11: MARKET TRENDS

  • Business strategies

  • Geopolitical uncertainties

  • Increasing healthcare expenditure

PART 12: VENDOR LANDSCAPE

  • Overview

  • Landscape disruption

  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered

  • Vendor classification

  • Market positioning of vendors

  • AbbVie Inc.

  • Alliance Pharma Plc

  • Bausch Health Companies, Inc.

  • Bayer AG

  • Eli Lilly and Co.

  • Encore Dermatology Inc.

  • LEO Pharma AS

  • Mylan NV

  • Pfizer Inc.

  • Sanofi

PART 14: APPENDIX

  • Research methodology

  • List of abbreviations

  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200925005337/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/